Korbinian Löbmann

7.0k total citations · 1 hit paper
121 papers, 6.0k citations indexed

About

Korbinian Löbmann is a scholar working on Pharmaceutical Science, Materials Chemistry and Food Science. According to data from OpenAlex, Korbinian Löbmann has authored 121 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Pharmaceutical Science, 68 papers in Materials Chemistry and 20 papers in Food Science. Recurrent topics in Korbinian Löbmann's work include Drug Solubulity and Delivery Systems (95 papers), Crystallization and Solubility Studies (51 papers) and Advanced Drug Delivery Systems (26 papers). Korbinian Löbmann is often cited by papers focused on Drug Solubulity and Delivery Systems (95 papers), Crystallization and Solubility Studies (51 papers) and Advanced Drug Delivery Systems (26 papers). Korbinian Löbmann collaborates with scholars based in Denmark, Finland and Germany. Korbinian Löbmann's co-authors include Thomas Rades, Holger Grohganz, Riikka Laitinen, Clare J. Strachan, Swapnil J. Dengale, Katrine Tarp Jensen, Matthias Manne Knopp, Georgia Kasten, Keith C. Gordon and Wenqi Wu and has published in prestigious journals such as Analytical Chemistry, The Journal of Physical Chemistry B and Advanced Drug Delivery Reviews.

In The Last Decade

Korbinian Löbmann

121 papers receiving 6.0k citations

Hit Papers

Recent advances in co-amorphous drug formulations 2016 2026 2019 2022 2016 100 200 300

Peers

Korbinian Löbmann
Korbinian Löbmann
Citations per year, relative to Korbinian Löbmann Korbinian Löbmann (= 1×) peers Holger Grohganz

Countries citing papers authored by Korbinian Löbmann

Since Specialization
Citations

This map shows the geographic impact of Korbinian Löbmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Korbinian Löbmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Korbinian Löbmann more than expected).

Fields of papers citing papers by Korbinian Löbmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Korbinian Löbmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Korbinian Löbmann. The network helps show where Korbinian Löbmann may publish in the future.

Co-authorship network of co-authors of Korbinian Löbmann

This figure shows the co-authorship network connecting the top 25 collaborators of Korbinian Löbmann. A scholar is included among the top collaborators of Korbinian Löbmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Korbinian Löbmann. Korbinian Löbmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arnous, Anis, et al.. (2024). Investigating the influence of protein secondary structure on the dissolution behavior of β-lactoglobulin-based amorphous solid dispersions. International Journal of Pharmaceutics. 653. 123887–123887. 5 indexed citations
2.
Leng, Donglei, et al.. (2024). Exploring the effect of protein secondary structure on the solid state and physical stability of protein-based amorphous solid dispersions. European Journal of Pharmaceutics and Biopharmaceutics. 198. 114274–114274. 3 indexed citations
3.
Leng, Donglei, et al.. (2023). Enhanced dissolution rate of nimodipine through β-lactoglobulin based formulation. International Journal of Pharmaceutics. 635. 122693–122693. 6 indexed citations
4.
Svedlindh, Peter, et al.. (2022). Hyperthermia-Induced In Situ Drug Amorphization by Superparamagnetic Nanoparticles in Oral Dosage Forms. ACS Applied Materials & Interfaces. 14(19). 21978–21988. 19 indexed citations
5.
Merkl, Padryk, Matthias Manne Knopp, Ragna Berthelsen, et al.. (2021). Utilizing Laser Activation of Photothermal Plasmonic Nanoparticles to Induce On-Demand Drug Amorphization inside a Tablet. Molecular Pharmaceutics. 18(6). 2254–2262. 11 indexed citations
6.
Merkl, Padryk, Matthias Manne Knopp, Ragna Berthelsen, et al.. (2021). The Effect of the Molecular Weight of Polyvinylpyrrolidone and the Model Drug on Laser-Induced In Situ Amorphization. Molecules. 26(13). 4035–4035. 2 indexed citations
7.
Merkl, Padryk, Matthias Manne Knopp, Ragna Berthelsen, et al.. (2021). The Influence of Drug–Polymer Solubility on Laser-Induced In Situ Drug Amorphization Using Photothermal Plasmonic Nanoparticles. Pharmaceutics. 13(6). 917–917. 2 indexed citations
8.
Knopp, Matthias Manne, et al.. (2021). Microwave-Induced in Situ Drug Amorphization Using a Mixture of Polyethylene Glycol and Polyvinylpyrrolidone. Journal of Pharmaceutical Sciences. 110(9). 3221–3229. 7 indexed citations
9.
Salar-Behzadi, Sharareh, et al.. (2020). Hot Melt Coating of Amorphous Carvedilol. Pharmaceutics. 12(6). 519–519. 9 indexed citations
10.
Kasten, Georgia, et al.. (2019). Process Optimization and Upscaling of Spray-Dried Drug-Amino acid Co-Amorphous Formulations. Pharmaceutics. 11(1). 24–24. 21 indexed citations
11.
Bohr, Adam, Thaís Leite Nascimento, Necati Harmankaya, et al.. (2019). Efflux Inhibitor Bicalutamide Increases Oral Bioavailability of the Poorly Soluble Efflux Substrate Docetaxel in Co-Amorphous Anti-Cancer Combination Therapy. Molecules. 24(2). 266–266. 17 indexed citations
12.
Kasten, Georgia, et al.. (2018). In vitro and in vivo comparison between crystalline and co-amorphous salts of naproxen-arginine. European Journal of Pharmaceutics and Biopharmaceutics. 132. 192–199. 44 indexed citations
13.
Kasten, Georgia, Korbinian Löbmann, Holger Grohganz, & Thomas Rades. (2018). Co-former selection for co-amorphous drug-amino acid formulations. International Journal of Pharmaceutics. 557. 366–373. 96 indexed citations
14.
Edinger, Magnus, et al.. (2018). Quantification of microwave-induced amorphization of celecoxib in PVP tablets using transmission Raman spectroscopy. European Journal of Pharmaceutical Sciences. 117. 62–67. 37 indexed citations
15.
Ruggiero, Michael T., Eric Ofosu Kissi, Juraj Šibík, et al.. (2017). The significance of the amorphous potential energy landscape for dictating glassy dynamics and driving solid-state crystallisation. Physical Chemistry Chemical Physics. 19(44). 30039–30047. 55 indexed citations
16.
Löbmann, Korbinian, Petra A. Priemel, Holger Grohganz, et al.. (2017). Influence of PVP molecular weight on the microwave assisted in situ amorphization of indomethacin. European Journal of Pharmaceutics and Biopharmaceutics. 122. 62–69. 34 indexed citations
17.
Beyer, Andreas, Holger Grohganz, Korbinian Löbmann, Thomas Rades, & Claudia S. Leopold. (2016). Influence of the cooling rate and the blend ratio on the physical stability of co-amorphous naproxen/indomethacin. European Journal of Pharmaceutics and Biopharmaceutics. 109. 140–148. 36 indexed citations
18.
Knopp, Matthias Manne, Korbinian Löbmann, David Elder, Thomas Rades, & René Holm. (2015). Recent advances and potential applications of modulated differential scanning calorimetry (mDSC) in drug development. European Journal of Pharmaceutical Sciences. 87. 164–173. 55 indexed citations
19.
Jensen, Katrine Tarp, Lasse Ingerslev Blaabjerg, Klaus Knop, et al.. (2015). Solid-state properties and dissolution behaviour of tablets containing co-amorphous indomethacin–arginine. European Journal of Pharmaceutics and Biopharmaceutics. 96. 44–52. 82 indexed citations
20.
Löbmann, Korbinian, Riikka Laitinen, Holger Grohganz, et al.. (2012). A theoretical and spectroscopic study of co-amorphous naproxen and indomethacin. International Journal of Pharmaceutics. 453(1). 80–87. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026